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Monocyte chemoattractant protein-1 and osteopontin differen- The infiltration of mononuclear cells into the glomeru-
tially regulate monocytes recruitment in experimental glomer- lus and the renal tubulointerstitium are hallmarks of
ulonephritis. almost any human glomerulonephritis (GN). Tubulo-Background. This study evaluated the mechanisms of mono-
interstitial cell infiltrates in particular correlate with dis-cyte/macrophage (M/M) infiltration in a rat model of anti-
ease progression [1]. The chemokine molecule familyglomerular basement membrane glomerulonephritis (GN). We
focused on chemokines and osteopontin, which are known plays an important role in the regulation of leukocyte
regulators of M/M recruitment. recruitment in inflammatory renal diseases [2–4]. Che-
Methods. Using immunohistology, in situ hybridization, and mokines are small glycoproteins that stimulate leukocyteNorthern blotting, the expression levels of chemokines and
trafficking and mediate inflammation [5]. Based on theirosteopontin were evaluated in isolated glomeruli and tubules
structural and genetic characteristics, chemokines are4, 10, and 20 days after the induction of GN. In vivo blocking
experiments were performed by application of neutralizing divided into different families. The classification, which
antibodies against osteopontin and monocyte chemoattractant is based on structural characteristics, is made according
protein-1 (MCP-1). to the position of the cysteine residues in the amino acidResults. In nephritic animals, high glomerular MCP-1 and
sequences of the molecules. Four families of chemokinesRANTES (regulated upon activation normal T cell expressed
have been characterized to date. The first two cysteinesand secreted) expression levels were observed on days 4 and 10.
The tubular expression of MCP-1, however, was only slightly of the CC chemokine family are directly adjacent. The
enhanced. In contrast, tubular osteopontin production was most commonly investigated CC chemokines in renal dis-
maximally stimulated (day 10) and paralleled with peaks of
eases are monocyte chemoattractant protein-1 (MCP-1)albuminuria and tubulointerstitial M/M infiltration. Applica-
and regulated upon activation normal T-cell expressedtion of an anti-osteopontin antibody ameliorated tubulointer-
stitial and glomerular M/M recruitment, whereas treatment and secreted (RANTES). They exert their effects through
with an anti–MCP-1 antibody selectively reduced glomerular binding to chemokine receptors that are predominantly
M/M recruitment. However, tubulointerstitial M/M infiltration expressed on leukocytes. MCP-1 and RANTES-neutral-
remained unchanged.
izing approaches have shown to reduce renal cell infil-Conclusion. These studies show that chemokines and osteo-
tration and tissue damage in experimental models ofpontin are differentially expressed in glomeruli and tubules in
this model of GN. Chemokines play a primary role in the GN [6–11].
glomeruli, whereas osteopontin has a predominant role in tubu- Although a prominent pathophysiological role of
lointerstitial M/M recruitment. The roles of chemokines and monocyte/macrophage (M/M) migration into the tubu-osteopontin may thus be dependent on the renal compartment
lointerstitium is generally accepted, the responsibleand on the disease model.
mechanisms, which lead to inflammatory cell recruit-
ment, have remained largely unknown to date [12]. One
hypothesis is that in GN, albumin, filtered by the glomer-
ulus, leads to an increased protein uptake in tubularKey words: glomerular monocytes, tubulointerstitial monocytes, mac-
cells, which may result in the formation of chemoattrac-rophages, mononuclear cells, progressive renal disease, inflammatory
cell recruitment. tants and proinflammatory cytokines. As a result, tubulo-
interstitial inflammation may occur [13–16]. However,Received for publication June 8, 2000
very little in vivo evidence exists describing the responsi-and in revised form November 8, 2000
Accepted for publication November 20, 2000 ble mechanisms [13, 14]. The available data are based
on mostly in vitro studies [15, 16].Ó 2001 by the International Society of Nephrology
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Recently, osteopontin has been suggested to play an (4) Nephritis. Animals received 0.5 mL/100 g body
weight anti-GBM antiserum.important role in the pathophysiology of GN. Osteopon-
(5) Nephritis 1 anti-osteopontin. Animals receivedtin is a secreted phosphoprotein with potent in vitro
0.5 mL/100 g body weight anti-GBM antiserum 1 50 mgand in vivo chemoattractant effects on M/M [17, 18].
anti-osteopontin antibody.Osteopontin blockade inhibits glomerular and tubuloin-
(6) Nephritis 1 anti-MCP-1. Animals received 0.5 mL/terstitial inflammatory cell recruitment [19, 20]. Thus,
100 g body weight anti-GBM antiserum 1 1 mL poly-chemokines and osteopontin play a central role in the
clonal anti-MCP-1 antibodies.regulation of renal leukocyte infiltration. To characterize
(7) Nephritis 1 anti-osteopontin 1 anti-MCP-1. Ani-these potential mechanisms further, we studied the ex-
mals received 0.5 mL/100 g body weight anti-GBM anti-pression levels of MCP-1, RANTES, and osteopontin in
serum 1 50 mg anti-osteopontin antibody 1 1 mL poly-isolated glomeruli and proximal tubules in a rat model
clonal anti-MCP-1 antibodies.of anti-glomerular basement membrane (GBM) GN.
All animal groups were studied on days 4, 10, and 20In our studies, the induction of anti-GBM GN led to
following the induction of GN. The experiments werea rapid increase in the glomerular expression of MCP-1
carried out in three complete separate sets (N 5 6 ani-and RANTES. In proximal tubules, however, osteopon-
mals for each group and time point, except for anti-tin expression was predominantly elevated. An osteo-
osteopontin and anti-MCP-1 experiments, which werepontin-neutralizing approach based on the application of
evaluated on day 10, only). Albuminuria was quantitatedan anti-osteopontin antibody reduced tubulointerstitial
by a urinary rat albumin-specific competitive enzyme-and, to a certain degree, glomerular M/M recruitment. In
linked immunosorbent assay (WAK Chemie Medicalcontrast, MCP-1 blockade ameliorated glomerular M/M
GmbH, Bad Soden, Germany).infiltration but did not influence tubulointerstitial M/M
recruitment. Isolation of glomeruli and proximal tubules
In summary, our data suggest a differential glomerular
Glomeruli were isolated by a fractional sieving tech-and tubular expression pattern of chemokines and osteo-
nique as described earlier [22]. Microscopic analysis re-pontin. Neutralization of osteopontin primarily reduces
vealed that in approximately 40 to 70%, the Bowman’stubulointerstitial M/M infiltration, whereas in this model
capsules remained intact after isolation of the glomeruliof experimental GN, MCP-1 plays a dominant role in
(data not shown). Proximal tubules were isolated fromthe glomerulus.
rats according to Vinlay, Gougoux, and Lemieux [23].
In brief, kidneys were perfused with 20 mL phosphate-
buffered saline (PBS) and 20 mL collagenase (1 mg/mL;METHODS
Biochrom KG, Berlin, Germany). Minced kidneys wereInduction of glomerulonephritis and
incubated in collagenase 1 mg/mL for 30 minutes at 378Cexperimental design
and gassed with oxygen. Homogenized kidneys were
Anti-glomerular basement membrane GN was in- sieved through a 425 mm sieve, and the pellet was washed
duced in male Wistar rats (140 to 160 g/body weight) by three times in ice-cold PBS and centrifuged three times
an intravenous injection of 0.5 mL/100 g body weight at 800 r.p.m. for three minutes. The pellet was resus-
of an anti-GBM antiserum [21]. Pre-immunization was pended in 50% Percoll solution (Amersham Pharmacia
done with 0.5 mg Hunter Titer Max (Sigma, St. Louis, Biotech, Uppsala, Sweden) and centrifuged at 12,500
MO, USA) four days before anti-GBM antiserum appli- r.p.m. for 30 minutes. A glass pipette was used to isolate
cation. Anti-GBM antiserum was induced in rabbits by the proximal tubules. Tubules were centrifuged at 1000
repeated immunization with disrupted rat glomeruli. In- r.p.m. for three minutes and washed twice with PBS.
direct immunofluorescence revealed a faint linear glo- Microscopic examination of the proximal tubules
merular staining of IgG. All animal experiments were showed that more than 98% of the isolated material
conducted in accordance with the national guidelines. contained blue lysosomal inclusions demonstrating isola-
The following groups of animals were studied (all groups tion of proximal tubule fragments [23].
were preimmunized):
RNA isolation and Northern blot hybridization(1) Control. Animals received 0.5 mL/100 g body
weight rabbit IgG. Cellular RNA from glomeruli and proximal tubules was
(2) Controls 1 anti-osteopontin. Animals received isolated using the guanidinium isothiocyanate method
50 mg anti-osteopontin antibody (MPIIIB10 Develop- [24]. For Northern blot analysis, total RNA (20 mg) was
mental Hybridoma Studies Institute, University of Iowa, size fractionated by electrophoresis on a 1.2% agarose-
Iowa City IA, USA). formaldehyde gel and transferred to nylon membranes
(3) Controls 1 anti–MCP-1. Animals received 1 mL (Zetabind; Cuno, Meriden, CT, USA). Equal loading of
the lanes was evaluated by ethidium bromide staining ofpolyclonal anti-MCP-1 antibodies [7].
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Fig. 1. Monocyte chemoattractant protein-1
(MCP-1), regulation upon activation-normal
T cell expressed and secreted (RANTES), and
osteopontin mRNA expression. Northern blot
analysis was performed of pooled RNA from
isolated glomeruli (A) and proximal tubules
(B) of six rats for each group and time point.
Quantitative results are shown as ratios rela-
tive to the control and to 18S RNA expression.
Data are expressed as means 6 SEM of three
independent experiments (#control vs. ne-
phritis P , 0.05; C ).
the 18S and 28S RNAs. The membranes were hybridized In situ hybridization
with a rat MCP-1 cDNA fragment, a rat RANTES cDNA, In situ hybridization was done using a previously pub-
and a rat osteopontin cDNA fragment, previously la- lished method [25]. Cryostat sections (10 mm thick) of
beled with a32P dCTP in hybridization buffer [5 3 SSPE, fresh frozen kidneys were thaw mounted onto slides and
2 3 Denhardt’s, 150 mg/mL sonicated and denatured fixed in 4% paraformaldehyde in PBS for 30 minutes.
salmon sperm DNA; Sigma; 0.1% sodium dodecyl sulfate After washing in PBS, sections were stored in 70% etha-
(SDS), 5% dextran sulfate, and 50% formamide] at 428C nol at 48C for further treatment. Before use, sections
for 18 hours as described earlier [22]. The membranes were brought to room temperature, washed twice with
were washed at high stringency in standard saline citrate PBS, and incubated in 0.1 mol/L triethanolamine, pH
(SSC)/SDS at 658C. Autoradiography was performed at 8.0, containing 0.25% acetic anhydride for 20 minutes.
2808C for 2 to 72 hours. Membranes were rehybridized Sections were then washed twice in PBS, dehydrated in
with a cDNA probe of 18S RNA to account for small an ascending alcohol series, and air dried.
loading and transfer variabilities. Exposed films were Prehybridization was performed overnight at 378C in
quantitated by using the phosphorimager Bio-Rad-GS- a humidified chamber with prehybridization buffer, con-
363 (multianalyst software). Northern blot experiments taining 50% formamide, 25 mmol/L ethylenediamine-
were performed independently in three different com- tetraacetic acid (EDTA), 50 mmol/L Tris-HCl, pH 7.6,
plete sets with quantitatively similar results. 2.5 3 Denhardt’s solution, 0.25 mg/mL tRNA (Boeh-
ringer Mannheim, Mannheim, Germany), and 20 mmol/L
Immunohistochemistry NaCl. Hybridization was performed overnight at 558C
Kidney tissues were either fixed in 1% buffered form- in hybridzation buffer [50% formamide, 20 mmol/L Tris-
aldehyde or in Methyl Carnoy’s solution. Tissue sections HCl, pH 7.5, 1 mmol/L EDTA, 1 3 Denhardt’s solution,
(2 mm) were stained with the alkaline phosphatase-anti- 0.5 mg/mL tRNA, 0.1 mg/mL poly (A) RNA (Sigma),
alkaline-phosphatase (APAAP) complex following ap- 0.1 mol/L dithiothreitol (DTT), and 10% dextran sulfate
plication of primary antibodies for immunohistology. (Sigma)]. Digoxigenin-labeled cRNA probes of rat os-
Tissue was stained with a monoclonal anti–ED-1 anti- teopontin were used at a concentration of approximately
body (Chemicon International, Temecula, CA, USA). 200 pg/mL hybridization buffer. After hybridization, cryo-
For immunolocalization of osteopontin, the monoclonal stat sections were washed twice in SSC containing 50%
anti-rat osteopontin antibody MPIIIB10 was used. All formamide.
quantitative morphologic analyses were performed in After washing, cryostat sections hybridized with digox-
blinded fashion. Evaluation of ED-1–positive cells was igenin-labeled probes were rinsed in SSC and equili-
brated with buffer 1 (100 mmol/L Tris-HCl, 150 mmol/Lperformed by counting positive cells in at least 80 glo-
meruli (range 80 to 110) of at least six kidneys at each NaCl, pH 7.5) for 10 minutes, followed by blocking for
30 minutes in buffer 2 [1% Boehringer blocking reagenttime point as described earlier [22]. Tubulointerstitial
M/M infiltration was assessed by counting ED-1–positive in buffer 1 1 0.5% bovine serum albumin (BSA)], and
incubated overnight at room temperature with a-DIG-APcells in 20 cortical high-power fields (3400) for each
section. antibodies at a dilution of 1:500 in modified buffer 2.
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Fig. 1. (Continued)
Panzer et al: Monocytes and macrophages in GN1766
Fig. 2. In situ hybridization of osteopontin expression. No cortical os- Fig. 3. Immunohistology of osteopontin expression. Immunohistologi-
teopontin mRNA expression was detectable in control animals (except cal analysis of osteopontin protein expression revealed a markedly
for small amounts in the Bowman’s capsules; A). Ten days after induc- increased tubular osteopontin expression in nephritic animals on day 10
tion of nephritis, osteopontin was markedly up-regulated in proximal (B), whereas control animals showed no detectable cortical osteopontin
tubular cells and, to a lesser degree, in glomerular parietal capsule cells protein expression (A). Original 3400.
(B). Original magnification 3200.
RESULTS
Sections were then washed twice for 15 minutes in buf- Glomerular and tubular expression of MCP-1,
fer 1, equilibrated for 2 minutes in buffer 3 (100 mmol/L RANTES, and osteopontin
Tris-HCl, 100 mmol/L NaCl, 50 mmol/L MgCl3, pH 9.5) The induction of anti-GBM nephritis led to increasedand developed overnight in the dark with buffer 3, con-
glomerular expression of MCP-1 and RANTES on days
taining 0.34 mg/mL 4-nitroblue tetrazolium chloride
4 and 10 when assessed by Northern blotting (Fig. 1A,
(Sigma), 0.175 mg/mL 5-bromo-4-chloro-3-indolyl phos- C). The expression levels of both chemokines returned
phate (Sigma), and 0.25 mg/mL levamisol. The develop- to control levels on day 20. Osteopontin expression in
ment of the reaction was terminated by washing with buf- glomeruli was up-regulated on day 10 only (Fig. 1A, C).
fer 4 (10 mmol/L Tris-HCl, 1 mmol/L EDTA, pH 8.0). A moderate increase in the expression of MCP-1 could
Sections were subsequently air dried and mounted. Spec- be found in the tubules on day 10, whereas RANTES
ificity of the hybridization signals was verified by using expression was unaltered. The tubular expression of
sense probes in parallel experiments under identical osteopontin increased on day 4 and peaked on day 10
hybridization conditions that always revealed negative (Fig. 1B, C).
staining.
Localization of osteopontin expression
Chemotactic assay In situ hybridization of osteopontin revealed low corti-
cal expression in the control group (Fig. 2A). Osteopon-Mouse osteopontin (R&D System, Minneapolis, MN,
tin expression increased on day 4 (data not shown) afterUSA) and rat MCP-1 (Tebu, Frankfurt, Germany) were
induction of the disease and reached a maximum on daytested for chemotactic potency on freshly isolated human
10 (Fig. 2B). Osteopontin RNA expression was primarilymonocytes (3 3 106 cells/mL) in a Boyden microchamber
localized in proximal tubules and, to a lesser degree, in[7]. The number of migrated monocytes was used as a
the area of the Bowman’s capsules (Fig. 2B). The senseparameter for the chemoattractant activity. To show the
probe showed no staining (data not shown). Osteopontinspecificity of osteopontin and MCP-1–induced chemo-
expression returned to control levels on day 20 (data nottaxis, blocking experiments were performed using the
shown). Osteopontin protein expression was studied byanti-osteopontin antibody MPIIIB10 and a polyclonal
immunohistology, which demonstrated almost identicalrabbit anti-rat MCP-1 antiserum [7].
results compared with in situ hybridization (Fig. 3A, B).
No osteopontin was detected in glomeruli on day 10.Statistical analysis
However, proximal tubular cells showed strong positivity
Results are expressed as means 6 SEM unless other- for osteopontin in nephritic animals (Fig. 3B).
wise stated. Statistical significance was defined as P ,
Glomerular and tubulointerstitial monocyte/0.05. To compare two distinct treatment groups (that is,
macrophage recruitmentnephritic vs. control or nephritic vs. treated animals), we
applied the Mann–Whitney test. Results of the Mann– Induction of GN resulted in a significant increase of glo-
Whitney test always correspond to comparison of ne- merular [2.94 6 0.31 cells/glomerular cross-section (c/gcs)]
phritic versus enalapril-treated animals, unless otherwise and tubulointerstitial (2.59 6 0.59 cells/high-power field)
M/M recruitment on day 10 (P , 0.01 vs. control). Toindicated.
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Fig. 4. Chemotactic assay. Osteopontin and MCP-1–induced chemo-
taxis on freshly isolated monocytes was assessed in a chemotactic assay.
The number of migrated M/M under basal conditions was standardized
as 100%. Osteopontin and MCP-1 led to significantly increased chemo-
taxis (#P , 0.01 vs. basal group). Application of the anti-osteopontin
and anti–MCP-1 antibodies blocked the induced chemotactic activity
(*P , 0.05).
test whether osteopontin and MCP-1 play a role in M/M
recruitment, nephritic animals were treated with an anti-
osteopontin antibody and an anti–MCP-1 antibody. Che-
motactic assay demonstrated that these antibodies blocked
MCP-1 or osteopontin-induced M/M migration in vitro
(Fig. 4). Blocking of osteopontin reduced glomerular
(1.99 6 0.28 c/gcs; P , 0.05 vs. nephritis; Figs. 5A and
6E) and tubulointerstitial infiltration of M/M on day 10
(1.4 6 0.07, P , 0.01 vs. nephritis; Figs. 5B and 6E). In Fig. 5. Glomerular and tubulointerstitial monocyte/macrophage infil-
contrast, application of a neutralizing anti-MCP-1 anti- tration. The infiltration of M/M into the glomerulus and tubulointersti-
tium was assessed immunohistochemically by using an antibody tobody markedly reduced glomerular M/M infiltration
ED-1. The induction of nephritis resulted in a significant increase in(1.33 6 0.09, P , 0.01 vs. nephritis; Figs. 5A and 6F) glomerular (A) and tubulointerstitial (B) M/M infiltration on day 10.
but did not influence tubulointerstitial M/M recruitment Treatment of nephritic animals with a monoclonal anti-osteopontin
antibody reduced glomerular and tubulointerstitial M/M recruitment (A(2.44 6 0.3; Figs. 5B, 6F). When control animals had
and B). In contrast, application of a neutralizing anti–MCP-1 antibodyreceived antibodies alone, M/M recruitment (Figs. 5 and
reduced glomerular M/M infiltration but did not influence tubulointer-6) remained unchanged. stitial M/M recruitment (A and B). Treatment of control animals with
antibodies to osteopontin and MCP-1 did not influence M/M recruit-
Albuminuria ment in comparison to the control group. Results are expressed as
means 6 SEM (#P , 0.01 vs. control; *P , 0.01 vs. nephritis; **P ,The induction of anti-GBM nephritis led to a signifi-
0.05 vs. nephritis).
cant increase in albuminuria on day 10 (10.77 mg 6
2.21/24 h, P , 0.01 vs. control; control group 0.05 mg 6
0.01/24 h). The treatment of nephritic animals with an
anti-osteopontin antibody (2.7 mg 6 0.39/24 h, P , 0.01 morphological feature of most types of GN. In animal
vs. nephritis) and an anti-MCP-1 antibody (1.1 mg 6 models of GN, chemokine-neutralizing or chemokine
0.08/24 h, P , 0.01 vs. nephritis) significantly reduced receptor-blocking approaches lead to a reduction of glo-
albuminuria on day 10. Twenty days after induction of merular mononuclear cell infiltrates [6–11]. This empha-
nephritis, albuminuria returned to baseline levels (data sizes the important role of locally produced chemokines
not shown). When control animals had received antibod- in immune-mediated glomerular injuries. However, much
ies alone, albuminuria remained unchanged (Fig. 7). less is known about the mechanisms that lead to tubulo-
interstitial inflammatory cell infiltration in GN, although
DISCUSSION tubulointerstitial leukocyte recruitment is a good pre-
dictor of disease progression [1]. One hypothesis is thatThe occurrence of monocytes/macrophages and T cells
in the glomerulus and renal tubulointerstitium is a typical in GN, the pathologic traffic of proteins that are filtered
Panzer et al: Monocytes and macrophages in GN1768
Fig. 7. Albuminuria. The induction of anti-GBM nephritis led to a
significant increase of albuminuria on day 10. Treatment with the anti-
osteopontin antibody and the anti–MCP-1 antibody reduced albumin-
uria. Results are expressed as means 6 SEM (N 5 6). #P , 0.01 vs.
control; *P , 0.01 vs. nephritis.
any time point examined. Since the animals developed
marked proteinuria, it is very unlikely that RANTES
plays a role in tubular cell-mediated M/M recruitmentFig. 6. Immunohistological staining of glomerular and tubulointersti-
tial monocyte/macrophage (M/M) infiltration Immunohistological stain- in this model of GN. While RANTES and MCP-1 expres-
ing of glomerular and tubulointerstitial M/M infiltration with a mono- sion levels were only low or absent, the tubular expres-clonal ED-1 antibody revealed a marked increase in ED-1–positive
sion of osteopontin was markedly increased on day 4cells 10 days after nephritis induction (D) in comparison to the control
group (A) and to control animals that had received the anti-osteopontin and peaked on day 10. In comparison to a recent study
antibody (B) or anti-MCP-1 antibody (C ). When nephritic animals had of nephrotoxic serum nephritis in mice [29], the differentreceived the anti-osteopontin antibody, glomerular and tubulointersti-
expression patterns of MCP-1 are at least in part attribut-tial ED-1–positive cells were substantially reduced (E), whereas applica-
tion of the neutralizing anti–MCP-1 antibody reduced glomerular M/M able to the use of a different model of renal injury and
recruitment but did not influence tubulointerstitial M/M infiltration (F). suggest a model- and compartment-dependent expres-Original magnification 3400.
sion and function of MCP-1. In situ hybridization showed
that increased osteopontin expression was in fact local-
ized in tubules and not in tubulointerstitial infiltrating
by the glomerulus leads to an increased protein uptake cells or blood vessels. Immunohistological analysis con-
in proximal tubular cells [12]. This in turn may have firmed these mRNA expression data and revealed selec-
functional relevance in the induction of inflammatory tive expression of osteopontin in tubules.
cytokines that might regulate cell recruitment. The CC In contrast to mRNA data from in situ hybridization
chemokines RANTES and MCP-1 in particular have studies of glomerular osteopontin expression, only a very
been claimed to play a central role in the regulation low amount of osteopontin protein was detected in glo-
of the tubulointerstitial infiltrate in primary glomerular meruli by immunohistology, which may be indicative of
damage [12–16]. Since osteopontin, which is a known differences in the sensitivity of the respective methods.
chemoattractant, has also been suggested to be involved In earlier studies, osteopontin, which is a secreted gly-
in tubulointerstitial M/M infiltration [26–28], we ana- cosylated phosphoprotein, was shown to be colocalized
lyzed chemoattractants in a rat model of anti-GBM dis- with glomerular and tubular macrophages [13, 30]. It
ease with specific focus on potential glomerular and tu- was postulated that osteopontin plays a role in the migra-
bular expression. tion of M/M into the glomerulus and tubulointerstitium
Our data show that a substantial up-regulation of glo- in inflammatory and noninflammatory renal diseases [13,
merular MCP-1, RANTES, and osteopontin expression 26–28, 31–34]. A recent study demonstrated increased
levels occurs in anti-GBM nephritis on day 10. In contrast glomerular osteopontin expression in a rat model of cres-
to the glomerulus, only a weak expression of MCP-1 was centic GN [34]. However, glomerular osteopontin ex-
detected in tubules isolated from nephritic rats on day pression was predominantly localized to crescentic le-
sions, which were absent in this model of GN.10. No expression of tubular RANTES was detected at
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11. Chen S, Bacon KB, Li L, et al: In vivo inhibition of CC andTo investigate further whether osteopontin and
CX3C chemokine-induced leukocyte infiltration and attenuation
MCP-1 might in fact play a role in M/M recruitment of glomerulo-nephritis in Wistar-Kyoto (WKY) rats by vMIP-II.
J Exp Med 188:193–198, 1998in this model of anti–GBM-nephritis, the animals were
12. Remuzzi G, Bertani T: Pathophysiology of progressive nephropa-treated with an anti-osteopontin antibody and an anti–
thies. N Engl J Med 339:1448–1456, 1998
MCP-1 antibody. Treatment of nephritic rats with the 13. Abbate M, Zoja C, Corna D, et al: In progressive nephropathies,
overload of tubular cells with filtered proteins translates glomerularanti-osteopontin antibody reduced albuminuria and glo-
permeability dysfunction into cellular signal of interstitial inflam-merular and tubulointerstitial infiltration of M/M. In con-
mation. J Am Soc Nephrol 9:1213–1224, 1998
trast, application of an anti-MCP-1 antibody reduced 14. Zoja C, Donadelli R, Colleoni S, et al: Protein overload stimu-
lates RANTES production by proximal tubular cells dependingalbuminuria and glomerular M/M recruitment but did
on NF-kB activation. Kidney Int 53:1608–1615, 1998not influence tubulointerstitial M/M infiltration.
15. Wang Y, Chen J, Chen L, et al: Induction of monocyte chemoat-
In summary, our data show a sequential increase in tractant protein-1 in proximal tubule cells by urinary protein. J Am
Soc Nephrol 8:1537–1545, 1997chemokine and osteopontin expression levels in glomer-
16. Wang Y, Rangan GK, Tay YC, et al: Induction of monocyteuli and proximal tubules. Tubular osteopontin expres- chemoattractant protein-1 by albumin is mediated by nuclear factor
sion is paralleled with the maximum concentration of KB in proximal tubule cells. J Am Soc Nephrol 10:1204–1213, 1999
17. Giachelli CM, Lombardi D, Johnson RJ, et al: Evidence forproteinuria and the occurrence of tubulointerstitial M/M
a role of osteopontin in macrophage infiltration in response toinfiltration. The markedly reduced infiltration of M/M pathological stimuli in vivo. Am J Pathol 152:352–358, 1998
into the tubulointerstitium after osteopontin neutraliza- 18. Denhardt DT, Guo X: Osteopontin a protein with diverse func-
tion. FASEB J 7:1475–1482, 1993tion demonstrates a unique role of osteopontin in tubulo-
19. Yu XQ, Nikolic-Paterson DJ, Mu W, et al: A functional role for
interstitial inflammatory cell recruitment, whereas in this osteopontin in experimental crescentic glomerulonephritis in the
rat. Proc Assoc Am Physicians 110:50–64, 1998model of experimental GN, MCP-1 function on mono-
20. Okada H, Moriwaki K, Kalluri R, et al: Osteopontin expressedcytes plays a dominant role in the glomerulus.
by renal tubular epithelium mediates interstitial monocyte infiltra-
tion in rats. Am J Physiol 278:F110–F121, 2000
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